Welcome to our dedicated page for PACS Group SEC filings (Ticker: PACS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The PACS Group, Inc. (NYSE: PACS) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As a healthcare holding company in the post-acute care and medical care facilities space, PACS uses SEC reports to describe its facility portfolio, credit arrangements, governance, and risk profile.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed discussions of PACS Group’s operations, financial condition, and risk factors. These filings also provide context on the company’s role as a holding company, the structure of its independent operating subsidiaries, and the separation between licensed healthcare providers and non-provider entities. AI-generated highlights can point out key sections on post-acute care operations, use of credit facilities, and lease obligations.
Current reports on Form 8-K are particularly important for PACS, given its history of restatements, credit agreement amendments, and NYSE listing updates. Recent 8-K filings have addressed topics such as forbearance and amendments under the company’s amended and restated credit agreement, events of default and related waivers, NYSE listing extensions tied to delayed SEC filings, and the completion of an independent Audit Committee investigation and related restatements. AI summaries can help users quickly understand the implications of these events.
Users can also access proxy materials such as the Definitive Proxy Statement on Schedule 14A, which outlines matters presented to stockholders at the annual meeting, including director elections, auditor ratification, and advisory votes on executive compensation. In addition, the filings page provides real-time updates from EDGAR and convenient access to other forms, such as notifications of late filings on Form 12b-25. Together, these documents offer a comprehensive view of PACS Group’s regulatory history, governance decisions, and financial reporting, with AI tools available to simplify and explain complex disclosures.
PACS Group, Inc. Chief Accounting Officer Michelle Renee Lewis reported a routine tax-withholding transaction related to equity compensation. On the vesting of previously granted restricted stock units, 24,691 shares of common stock were withheld at $33.14 per share to cover tax liabilities, rather than sold in the open market. After this withholding, Lewis directly holds 385,338 shares of PACS Group common stock, indicating she retains a substantial equity position following the compensation-related event.
PACS Group, Inc. Chief Legal Officer and Secretary John Todd Mitchell reported a routine tax-related share disposition. On the reported date, 66,471 shares of common stock were withheld at a value of $33.14 per share to cover tax liabilities tied to vesting restricted stock units. After this withholding, he directly held 883,718 shares of PACS Group common stock, indicating he retained a substantial equity position.
PACS Group, Inc. President & COO Joshua Jergensen reported a tax-withholding disposition related to equity compensation. On the vesting of previously granted restricted stock units, 197,525 shares of common stock were withheld at $33.14 per share to cover tax liabilities. After this non-market transaction, Jergensen directly holds 2,616,320 shares of PACS Group common stock, indicating this was a routine compensation-related tax event rather than an open-market sale.
Priegnitz Kelly reported acquisition or exercise transactions in this Form 4 filing.
PACS Group, Inc. reported that Chief Compliance Officer Kelly Priegnitz received a grant of 8,203 restricted stock units of common stock. These RSUs vest in three substantially equal annual installments starting on March 24, 2026, and will deliver one share per unit at vesting. Following this award, Priegnitz directly holds 38,203 shares of common stock.
PACS Group, Inc. Chief Human Resources Officer Trent Dean Bingham reported an equity compensation grant on Common Stock. He acquired 14,649 restricted stock units (RSUs) for no cash payment, increasing his directly held equity-related position to 39,649 shares/units reported after the transaction.
The RSUs convert into one share of Common Stock each upon vesting. They are scheduled to vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, contingent on his continued service through each vesting date.
Lewis Michelle Renee reported acquisition or exercise transactions in this Form 4 filing.
PACS Group, Inc. reported that Chief Accounting Officer Michelle Renee Lewis received a grant of 35,159 restricted stock units (RSUs) of Common Stock. Each RSU represents the right to receive one share upon vesting. Following this equity award, she now holds 410,029 shares directly, including these RSUs.
The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, and vesting is conditioned on her continued service with the company through each vesting date.
MITCHELL JOHN TODD reported acquisition or exercise transactions in this Form 4 filing.
PACS Group, Inc. reported that Chief Legal Officer and Secretary John Todd Mitchell received a grant of 82,039 shares of Common Stock in the form of restricted stock units. These RSUs vest in three substantially equal annual installments starting on the first anniversary of March 24, 2026, contingent on his continued service. Following this award, he directly holds 950,189 shares of the company’s Common Stock, reflecting a significant ongoing equity stake aligned with long-term performance.
Jergensen Joshua reported acquisition or exercise transactions in this Form 4 filing.
PACS Group, Inc. reported that President & COO Joshua Jergensen received an award of 146,498 restricted stock units (RSUs) of Common Stock. After this grant, he holds 2,813,845 shares directly. The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to his continued service.
PACS Group, Inc. director and officer Mark Hancock received an equity award in the form of 98,154 restricted stock units (RSUs) of Common Stock. Each RSU converts into one share upon vesting and the award was reported at a price of $0.00 per share, indicating a compensation grant rather than a market purchase.
The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, conditioned on Hancock’s continued service. Following this grant, Hancock directly holds 54,602,597 shares of Common Stock, making the award relatively small compared with his overall reported holdings.
PACS Group, Inc. director and Co-Founder, CEO & Chairman Murray Jason Hulse reported an equity compensation award in the form of restricted stock units. He received 234,397 RSUs of Common Stock at a grant price of $0.00 per share, classified as a grant or award acquisition. These RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to his continued service. Following this grant, his directly held Common Stock position reported in this filing is 55,081,532 shares.